Introduction Previously, I wrote regarding the Innova Medical Group Inc (Innova) and the government contracts…
Confidentiality matters – employees
Introduction Employee confidentiality is a subject frequently taken for granted. Previously, I wrote of confidentiality…
Intellectual property and R&D
Introduction Frequently with transactional R&D, consideration of the intellectual property (IP) position, as well as…
Out of control – Innova lateral flow test
Introduction Project Moonshot was the government’s polymerase chain reaction (PCR) mass testing programme for SARS-CoV-2,…
IPdoxx provides specialist IP support for growing businesses
Intellectual property (IP) barrister and specialist Scott Farnsworth has developed and launched a new and…
ABPI find that restarting non-coronavirus (COVID-19) research needs new strategy
The Association of the British Pharmaceutical Industry (ABPI) has published its second annual report on…
IPO issues guidance for identifying misleading invoices
The Intellectual Property Office (IPO) has issued guidance for identifying misleading invoices, and what customers…
EMA starts first rolling review of a COVID-19 vaccine in the EU
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has started the first rolling review…
Government publishes report on R&D in Creative Industries Survey
The Department for Digital, Culture, Media & Sport has published a report on research and…
English courts can determine FRAND terms for portfolios of standard essential patents
Introduction The Supreme Court has handed down its first judgment concerning the obligations upon the…